AI Article Synopsis
- TAVR (Transcatheter Aortic Valve Replacement) was approved in the U.S. in 2011 as a less invasive option for patients with severe aortic stenosis who cannot undergo traditional surgery.
- Since 2002, over 20,000 TAVR procedures have been performed worldwide, beginning with the first successful procedure by Alain Cribier.
- The paper examines the performance of different types of aortic stent valves, compares them with traditional surgical methods, reviews complications, and highlights future challenges for improving TAVR outcomes.
Article Abstract
Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011, providing a critically needed alternative therapy for patients with severe aortic stenosis previously refused surgical aortic valve replacement (SAVR). Over 20,000 TAVR have been performed in patients worldwide since 2002 when Alain Cribier performed the first-in-man TAVR. This paper reviews the data from balloon expandable and self-expanding aortic stent valves as well as data comparing them with traditional surgical aortic valve replacement (SAVR). Complications using criteria established by the Valve Academic Research Consortium (VARC) are reviewed. Future challenges and possibilities are discussed and will make optimizing TAVR an important goal in the years to come.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431975 | PMC |
| http://dx.doi.org/10.4137/CMC.S7540 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!